Andrew E. Whiteley

Andrew E. Whiteley

Auto-generated profile, based on publicly available information

Andrew E. Whiteley

California Polytechnic State University, San Luis Obispo

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Cell
Verified
Journal Article
Closed access
WSWilliam J. Sullivan
William J. Sullivan
PMPeter J. Mullen
Peter J. Mullen
ESErnst W. Schmid
Ernst W. Schmid
AFAimee Flores
Aimee Flores
MMMilica Momcilovic
Milica Momcilovic
HCHeather Christofk
Heather Christofk

5 May 2021 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
AWAndrew E. Whiteley
Andrew E. Whiteley
TPTrevor T. Price
Trevor T. Price
GCGaia Cantelli
Gaia Cantelli
DSDorothy A. Sipkins
Dorothy A. Sipkins

21 June 2024 in Science
Verified
Journal Article
Closed access
AWAndrew E. Whiteley
Andrew E. Whiteley
DMDanhui Ma
Danhui Ma
LWLihua Wang
Lihua Wang
SYSeok-Yeong Yu
Seok-Yeong Yu
CYClaire Yin
Claire Yin
DSDorothy A. Sipkins
Dorothy A. Sipkins
The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we show that BCCs in mice can invade the LM by abluminal migration along blood vessels that connect vertebral or calvarial bone marrow and meninges, bypassing the blood-brain barrier. This process is dependent on BCC engagement with vascular basement membrane laminin through expression of the neuronal pathfinding molecule integrin α6. Once in the LM, BCCs colocalize with perivascular meningeal macrophages and induce their expression of the prosurvival neurotrophin glial-derived neurotrophic factor (GDNF). Intrathecal GDNF blockade, macrophage-specific GDNF ablation, or deletion of the GDNF receptor neural cell adhesion molecule (NCAM) from BCCs inhibits breast cancer growth within the LM. These data suggest integrin α6 and the GDNF signaling axis as new therapeutic targets against breast cancer LM metastasis.

6 August 2021 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
SRSarah M. Ridge
Sarah M. Ridge
AWAndrew E. Whiteley
Andrew E. Whiteley
HYHisayuki Yao
Hisayuki Yao
TPTrevor T. Price
Trevor T. Price
MBMaegan L. Brockman
Maegan L. Brockman
DSDorothy A. Sipkins
Dorothy A. Sipkins
The majority of adult patients with acute lymphoblastic leukemia (ALL) suffer relapse, and in patients with central nervous system (CNS) metastasis, prognosis is particularly poor. We recently demonstrated a novel route of ALL CNS metastasis dependent on PI3Kδ regulation of the laminin receptor integrin α6. B-ALL cells did not, however, rely on PI3Kδ signaling for growth. Here we show that broad targeting of PI3K isoforms can induce growth arrest in B-ALL, reducing systemic disease burden in mice treated with a single agent pan-PI3Ki, copanlisib. Moreover, we show that cellular stress activates PI3K/Akt-dependent survival pathways in B-ALL, exposing their vulnerability to PI3Kδ and pan-PI3Ki. The addition of a brief course of copanlisib to chemotherapy delivered the combined benefits of increased survival, decreased systemic disease, and reduced CNS metastasis. These data suggest the promising, multifaceted potential of pan-PI3Ki for B-ALL CNS prophylaxis, systemic disease control, and chemosensitization.

30 January 2026 in ACS Chemical Biology
Verified
Journal Article
Closed access
JCJennifer L. Cordoza
Jennifer L. Cordoza
RJRachel A. Johnson
Rachel A. Johnson
AWAndrew E. Whiteley
Andrew E. Whiteley
CHCalista A. Horta
Calista A. Horta
JNJayna C. Nicholas
Jayna C. Nicholas
KWKatharine R. Watts
Katharine R. Watts

31 October 2025 in bioRxiv
Verified
Preprint
Open access
JCJennifer L. Cordoza
Jennifer L. Cordoza
RJRachel A. Johnson
Rachel A. Johnson
AWAndrew E. Whiteley
Andrew E. Whiteley
CHCalista A. Horta
Calista A. Horta
JNJayna C. Nicholas
Jayna C. Nicholas
KWKatharine R. Watts
Katharine R. Watts
Actinobacteria are a rich source of bioactive compounds and unique biosynthetic chemistry. Micromonospora echinospora subsp. challisensis NRRL 12255 produces the aromatic polyketide TLN-05220, which exhibits nanomolar activity against antibiotic-resistant human pathogens including vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus . The pentangular polyphenol core of TLN-05220 is decorated with a piperazinone moiety, yet the enzymes responsible for the construction of this uncommon modification from amino acid precursors are unknown. Synthetic piperazinone-containing molecules have diverse antimicrobial, antiviral, anticancer, and anti-inflammatory bioactivity profiles, and determining biosynthetic routes for the assembly of this heterocycle may enhance drug discovery and medicinal chemistry efforts. We identified a putative TLN-05220 biosynthetic gene cluster (BGC) in the commercially available strain M. echinospora ATCC 15837 containing both type-I and type-II polyketide synthases, two predicted asparagine synthetase-like enzymes, and two genes ( tln 1 and tln 5) that putatively encode pyridoxal 5’-phosphate (PLP)-dependent amino acid synthases. Stable isotopic feeding studies coupled with liquid chromatography–tandem mass spectrometry (LC–MS/MS), identified L-alanine, L-serine, and glycine as metabolic precursors of TLN-05220. Subsequent in vitro enzymology established that Tln1 is a PLP-dependent alanine racemase, while Tln5 performs a stereoselective β-substitution reaction of O -phospho-L-serine with a preferential D-alanine nucleophile. Alanine racemization and Tln5 pseudodipeptide L-serine-Cβ- N -D-alanine (D,L-PDP) incorporation into TLN-05220 were further supported using deuterated intermediates and mass spectrometry techniques. Establishing the enzymes that catalyze amino acid installation within TLN-05220 inspires further biosynthetic discovery and engineering while enabling the biocatalytic syntheses of novel amino acid-containing polyketide antibiotics. Graphical